Are you Dr. Gunn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4383 Medical Dr
Suite 4044
San Antonio, TX 78229Phone+1 210-593-5700Fax+1 210-593-5992
Summary
- Dr. Shelly Gunn, MD is a board certified pathologist in San Antonio, Texas. She is currently licensed to practice medicine in Texas, New Jersey, and Arizona.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Pathology-Anatomic and Clinical, 2003 - 2006- The University of Texas Health Science Center at San AntonioClass of 2002
Certifications & Licensure
AZ State Medical License 2019 - 2025
CA State Medical License 2007 - 2025
NJ State Medical License 2021 - 2025
NY State Medical License 2008 - 2025
TX State Medical License 2006 - 2024- American Board of Pathology Pathology - Clinical
Clinical Trials
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 341 citationsThe clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancerToshio Shimizu, Anthony W. Tolcher, Kyriakos P. Papadopoulos, Muralidhar Beeram, Drew W. Rasco
Clinical Cancer Research. 2012-04-15 - 43 citationsMultiparametric liquid biopsy analysis in metastatic prostate cancerEmmanuelle Hodara, Gareth Morrison, Alexander Cunha, Daniel Zainfeld, Tong Xu
JCI Insight. 2019-03-07 - 113 citationsClinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event.I-Tien Yeh, Mathew A Martin, Ryan S. Robetorye, Aswani R. Bolla, Chris McCaskill
Modern Pathology. 2009-09-01
Press Mentions
ResearchDx Appointment of New Chief Medical Officer to Meet NIH Push for Precision Medicine in Expediting Bench to Bedside” Strategies for Disease TreatmentDecember 7th, 2015
